GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings
Open accessThe DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index; 11 of the 24 sources its claims cite were checked for support.
Abstract
INTRODUCTION: The diagnosis of tuberculous lymphadenitis (TBL) remains challenging. The routinely used methods (cytology and smear microscopy) have sub-optimal sensitivity. Recently, WHO recommends GeneXpert to be used as the initial diagnostic test in patients suspected of having extra-pulmonary tuberculosis (EPTB). However, this was a conditional recommendation due to very low-quality evidence available and more studies are needed. In this study we evaluated the performance of Xpert for the diagnosis of TBL on concentrated fine needle aspirates (FNA) in Southwest Ethiopia. METHODS: FNA was collected from presumptive TBL cases. Two smears were prepared from each aspirate and processed for cytology and conventional microscopy. The remaining aspirate was treated with N-acetyl-L-cysteine-NaOH and centrifuged for 15minutes at 3000g. The concentrated sediment was used for culture and Xpert test. Capilia TB-Neo test was used to differentiate M. tuberculosis complex (MTBC) from non-tuberculous mycobacteria (NTM). Composite bacteriological methods (culture and/or smear microscopy) were considered as a reference standard. RESULT: Out of 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard (CRS). Xpert detected M. tuberculosis complex (MTBC) in 60.1% (86/143) of the presumptive TBL cases. The sensitivity of Xpert compared to CRS was 87.8% [95% CI: 81.0-94.5] and specificity 91.1% [95% CI: 82.8-99.4]. The sensitivity was 27.8% for smear microscopy and 80% for cytology compared to CRS. Cytology showed the lowest specificity (57.8%). Xpert was positive in 4 out of 45 culture- and smear-negative cases. Among 47 cytomorphologically non-TBL cases, 15 were positive on Xpert. More than half of Xpert-positive cases were in the range of very low cut-off threshold values (28<Ct<38). Resistance to rifampicin was identified in 4.7% (4/86) of Xpert-positive cases. CONCLUSION: Xpert test showed a high sensitivity and specificity for the diagnosis of TBL on concentrated FNA samples. In addition, Xpert offered rapid detection of rifampicin-resistant M. tuberculosis strains from lymph node aspirates.
Overview
CoChat Summary
TL;DR
This study evaluated GeneXpert MTB/RIF on concentrated fine needle aspirates from 143 presumptive tuberculous lymphadenitis (TBL) cases in Southwest Ethiopia and found high diagnostic accuracy versus a composite bacteriological reference standard. Xpert was much more sensitive than smear microscopy and also detected rifampicin resistance in a small subset of positives.
Key findings
- Among 143 enrolled suspects, 64.3% (92/143) were confirmed TBL cases by the composite reference standard; Xpert detected MTBC in 60.1% (86/143) of presumptive cases.
- Compared with the composite reference standard, Xpert had 87.8% sensitivity (95% CI 81.0–94.5) and 91.1% specificity (95% CI 82.8–99.4).
- Smear microscopy had 27.8% sensitivity, and cytology had 80.0% sensitivity but only 57.8% specificity.
- Rifampicin resistance was identified in 4.7% (4/86) of Xpert-positive cases; 53.5% (46/86) of Xpert-positive samples were “very low” and 44.2% (38/86) were “low” semi-quantitative categories.
Methods
- Prospective diagnostic study at Jimma University Specialized Hospital, Southwest Ethiopia; 143 consecutive outpatients clinically suspected of TBL were enrolled between May and September 2013.
- Fine needle aspirates were split for cytology, Ziehl-Neelsen smear microscopy, Löwenstein-Jensen culture, and Xpert MTB/RIF after NALC/NaOH concentration and centrifugation; Capilia TB-Neo was used to distinguish MTBC from NTM.
- Diagnostic performance was assessed using composite bacteriological methods (culture and/or smear microscopy) as the reference standard, with sensitivity, specificity, and predictive values calculated in SPSS.
Limitations
- The paper states that culture on LJ medium and/or smear microscopy is not sufficient to detect all TBL cases, so the reference standard could miss true cases.
- The authors note they did not include clinical outcomes, and they suggest future studies using liquid culture, histology, and/or clinical response to treatment as better standards.
- They cultured only one NTM isolate and did not speciate it, so the study cannot assess the contribution of NTM lymphadenitis in Ethiopia.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
5 Valid · 1 Not valid · 8 Not checked · 63 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Previous studies reported 98–100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
§ GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings > Discussion
What the sources say
- Not checked — no full text of the sourcecites [13] Biadglegne F, Mulu A, Rodloff AC, Sack U (2014) Diagnostic performance of the Xpert MTB/RIF assay for tuberculous lymphadenitis on fine needle aspirates from Ethiopia. Tuberculosis. 24931451 source
- Disputedcites [14] Hillemann D, Rüsch-Gerdes S, Boehme C, Richter E (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. Journal of clinical microbiology 49: 1202– 1205. 10.1128/JCM.02268-10 21270230 PMC3122824 sourceExperimental — accuracy not yet measured
The Results section on RMP resistance detection reports that all 29 isolates were phenotypically susceptible; among 26 determinate Xpert results, 25 agreed and one indicated resistance. The Discussion explicitly says no rifampin-resistant strain was isolated, so this study could not establish 98–100% agreement for detecting resistant strains. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Supportedcites [18] Helb D, Jones M, Story E, Boehme C, Wallace E, et al (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology 48: 229– 237. 10.1128/JCM.01463-09 19864480 PMC2812290 source
The Results report that Xpert identified all nine rifampin-resistant cases and classified 54 of 55 phenotypically susceptible cases as susceptible—63 of 64 classifications agreed with conventional susceptibility testing (98.4%). Sequencing suggested that the one discordant conventional result was erroneous; the reported 100% corrected specificity therefore depends on that discrepancy analysis, not agreement with the original phenotypic result. (LLM, conf=0.90)
- Supportedcites [26] Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, et al (2010) Rapid molecular detection of tuberculosis and rifampin resistance. New England Journal of Medicine 363: 1005– 1015. 10.1056/NEJMoa0907847 20825313 PMC2947799 source
The Abstract Results report that Xpert correctly identified 200 of 205 rifampin-resistant patients compared with phenotypic drug-susceptibility testing: 97.6%, or 98% rounded to a whole percentage. This supports the lower end of the 98–100% range attributed collectively to several cited studies; this paper's 100% figure applies only after sequencing resolved discrepancies, not to agreement with phenotypic testing. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.2%) [13].”
§ GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings > Discussion
What the sources say
- Partly supportedcites [20] Denkinger CM, Schumacher SG, Boehme CC, Dendukuri N, Pai M, et al (2014) Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a systematic review and meta-analysis. European Respiratory Journal: erj00078-02014. 24696113 sourceExperimental — accuracy not yet measured
The lymph-node TB section reports pooled Xpert specificity of 93.6% against culture and 99.1% against a composite reference standard; the TB meningitis section reports 97.8% against culture. These findings broadly support a comparison with high specificities in previous studies, but this paper does not report the cited 89–99% range. The 91% figure belongs to the citing authors’ current study, not this source. (LLM, conf=0.78)
- Not checked — no full text of the sourcecites [21] Penz E, Boffa J, Roberts D, Fisher D, Cooper R, et al (2015) Diagnostic accuracy of the Xpert® MTB/RIF assay for extra-pulmonary tuberculosis: A meta-analysis. The International Journal of Tuberculosis and Lung Disease 19: 278– 284. 10.5588/ijtld.14.0262 25686134 source
- Supportedcites [22] Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, et al (2011) Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. Journal of clinical microbiology 49: 3967– 3970. 10.1128/JCM.01310-11 21880965 PMC3209093 source
The Results (p. 3968) report Xpert specificity of 88.9%, which rounds to 89% and falls within the cited range. The 91% figure describes the citing authors’ current study, not a result attributed to this source. (LLM, conf=0.91)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, the sensitivity of Xpert in the current study is lower than what was found in similar study by Ligthelm et al (sensitivity, 96.7%) [22].”
§ GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings > Discussion
What the sources say
- Supportedcites [22] Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, et al (2011) Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. Journal of clinical microbiology 49: 3967– 3970. 10.1128/JCM.01310-11 21880965 PMC3209093 source
The Results (p. 3968) report that Xpert MTB/RIF identified 29 of 30 TB cases against the study’s reference standard, giving a sensitivity of 96.7%. The comparison with the citing authors’ current study is their own, not a result attributed to Ligthelm et al. (LLM, conf=0.95)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“Such cases (Xpert-positive but culture-negative) are likely to be true TB positives as corroborated by the high specificity [14,18] and by the fact that the procedure is less prone to contamination due to the closed reaction chamber (real-time PCR technology) of Xpert.”
§ GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings > Discussion
What the sources say
- Supportedcites [14] Hillemann D, Rüsch-Gerdes S, Boehme C, Richter E (2011) Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. Journal of clinical microbiology 49: 1202– 1205. 10.1128/JCM.02268-10 21270230 PMC3122824 source
The Results report 98.2% overall specificity, and the Discussion says the closed reaction chamber makes Xpert less prone to contamination. For seven Xpert-positive, culture-negative patients, the Discussion reports two with TB confirmed by other cultures and two with previously culture-confirmed TB, supporting the cautious inference that such results may be genuine; it also notes that three discrepancies could not be resolved. (LLM, conf=0.84)
- Supportedcites [18] Helb D, Jones M, Story E, Boehme C, Wallace E, et al (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology 48: 229– 237. 10.1128/JCM.01463-09 19864480 PMC2812290 source
The Results report 100% specificity in the clinical validation sample and describe two Xpert-positive, initially culture-negative sputum samples from patients whose second samples were culture-positive. The Discussion says closed cartridges mitigate false positives caused by carryover contamination. Together, these passages support the qualified claim that such cases are likely to be true TB positives. (LLM, conf=0.90)
hedgedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“In agreement with other studies [9,18,22], Xpert has a higher sensitivity than smear microscopy.”
§ GeneXpert MTB/RIF Assay for the Diagnosis of Tuberculous Lymphadenitis on Concentrated Fine Needle Aspirates in High Tuberculosis Burden Settings > Discussion
What the sources say
- Not checked — no full text of the sourcecites [9] Al-Ateah SM, Al-Dowaidi MM, El-Khizzi NA (2012) Evaluation of direct detection of Mycobacterium tuberculosis complex in respiratory and non-respiratory clinical specimens using the Cepheid Gene Xpert® system. Saudi medical journal 33: 1100– 1105. 23047207 source
- Supportedcites [18] Helb D, Jones M, Story E, Boehme C, Wallace E, et al (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. Journal of clinical microbiology 48: 229– 237. 10.1128/JCM.01463-09 19864480 PMC2812290 source
The Results section states that Xpert MTB/RIF’s limit of detection in sputum was at least two orders of magnitude more sensitive than the AFB smear. The clinical validation results also report Xpert detection in culture-positive, smear-negative samples. (LLM, conf=0.94)
- Supportedcites [22] Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, et al (2011) Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. Journal of clinical microbiology 49: 3967– 3970. 10.1128/JCM.01310-11 21880965 PMC3209093 source
In the Results (p. 3968), Xpert identified 29 of 30 TB cases and was positive in all six smear-negative, culture-positive cases. These findings support higher sensitivity than smear microscopy for the fine-needle-aspiration specimens studied. (LLM, conf=0.90)
plainstates an associationn = 2- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
43 more claims
Create a free account to see all 77 claims and to verify the 2 references still open.
- It may state two separate claims as one. 18
- Probably not a substantial claim. 15
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“This finding is lower than another study from Ethiopia done by Mulualem et al (sensitivity, 87.8%) [29].”
From Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis (2019) · cites this paper as [29]
The cited source says what the claim attributes to it.
In the citing paper
“Overall, cytology lacks specificity but has high sensitivity [31,32].”
From Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis (2019) · cites this paper as [32]
Citations
Cites
Rapid Molecular Detection of Tuberculosis and Rifampin Resistance
Boehme, C. C., Nabeta, P., Hillemann, D., Nicol, M. P., Shenai, S., Krapp, F., Allen, J., Tahirli, R., Blakemore, R., Rustomjee, R., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0907847 · Cited by 2,309 · cited 1×
“Previous studies reported 98– 100% agreement in detection of rifampicin resistance strains using the Xpert test and phenotypic drug susceptibility test [13,14,18,26].”
Helb, D., Jones, M., Story, E., Boehme, C., Wallace, E., Ho, K., Kop, J., Owens, M. R., Rodgers, R., Banada, P., et al. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01463-09 · Cited by 914
Denkinger, C. M., Schumacher, S. G., Boehme, C. C., Dendukuri, N., Pai, M., & Steingart, K. R. (2014) · European Respiratory Journal · doi:10.1183/09031936.00007814 · Cited by 527 · cited 2×
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.”
ResultRapid Molecular Detection of Extrapulmonary Tuberculosis by the Automated GeneXpert MTB/RIF System
Hillemann, D., Rüsch-Gerdes, S., Boehme, C., & Richter, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02268-10 · Cited by 413
Identification of the Causative Organism of Tuberculous Lymphadenitis in Ethiopia by PCR
Kidane, D., Olobo, J. O., Habte, A., Negesse, Y., Aseffa, A., Abate, G., Yassin, M. A., Bereda, K., & Harboe, M. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.11.4230-4234.2002 · Cited by 126 · cited 1×
“Cytology and conventional smear microscopy have been used as the initial diagnostic tools for TBL in resource poor settings [4,5].”
MethodLigthelm, L. J., Nicol, M. P., Hoek, K. G. P., Jacobson, R., van Helden, P. D., Marais, B. J., Warren, R. M., & Wright, C. A. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.01310-11 · Cited by 123 · cited 2×
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.”
ResultA multisite assessment of the quantitative capabilities of the Xpert MTB/RIF assay
Blakemore, R., Nabeta, P., Davidow, A. L., Vadwai, V., Tahirli, R., Munsamy, V., Nicol, M., Jones, M., Persing, D. H., Hillemann, D., et al. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201103-0536oc · Cited by 118
Diagnostic accuracy of the Xpert® MTB/RIF assay for extra-pulmonary tuberculosis: a meta-analysis
Penz, E., Boffa, J., Roberts, D. J., Fisher, D., Cooper, R., Ronksley, P. E., & James, M. T. (2015) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0262 · Cited by 97 · cited 2×
“The specificity (91%) of the Xpert in the current study was found to be consistent with previous studies reported by others (specificity, 89–99%) [20,21,22], but higher than the study done by Biadigilegn et al (specificity, 69.”
Result(1992) · PubMed · Cited by 88
Wright, C. A., van der Burg, M., Geiger, D., Noordzij, J. G., Burgess, S. M., & Marais, B. J. (2008) · Diagnostic Cytopathology · doi:10.1002/dc.20788 · Cited by 84 · cited 3×
“FNA cytology as an inexpensive and reliable tool for TBL has been studied by a number of investigators [4,24,25].”
BackgroundMethod
Cited by
Xpert ® MTB/RIF assay for extrapulmonary tuberculosis and rifampicin resistance
Kohli, M., Schiller, I., Dendukuri, N., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub2 · Cited by 245
Kohli, M., Schiller, I., Dendukuri, N., Yao, M., Dheda, K., Denkinger, C. M., Schumacher, S. G., & Steingart, K. R. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012768.pub3 · Cited by 215
Kay, A. W., Fernández, L. G., Takwoingi, Y., Eisenhut, M., Detjen, A., Steingart, K. R., & Mandalakas, A. M. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013359.pub2 · Cited by 154
Ganchua, S. K. C., Cadena, A. M., Maiello, P. A., Gideon, H. P., Myers, A. J., Junecko, B. A. F., Klein, E. C., Lin, P. L., Mattila, J. T., & Flynn, J. L. (2018) · PLoS Pathogens · doi:10.1371/journal.ppat.1007337 · Cited by 102
Xpert MTB/RIF Ultra assay for tuberculosis disease and rifampicin resistance in children
Kay, A. W., Ness, T. E., Verkuijl, S. E., Viney, K. A., Brands, A., Masini, T., Fernández, L. G., Eisenhut, M., Detjen, A., Mandalakas, A. M., et al. (2022) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd013359.pub3 · Cited by 124
Needle Biopsy Adequacy in the Era of Precision Medicine and Value-Based Health Care
Pritzker, K. P. H., & Nieminen, H. J. (2019) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2018-0463-ra · Cited by 64
Xpert MTB/RIF assay for the diagnosis of extrapulmonary tuberculosis: a diagnostic evaluation study
Tadesse, M., Abebe, G., Bekele, A., Bezabih, M., Yilma, D., Apers, L., de Jong, B. C., & Rigouts, L. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.12.018 · Cited by 55
Self-citationYu, G., Zhong, F., Ye, B., Xu, X., Chen, D., & Shen, Y. (2019) · BioMed Research International · doi:10.1155/2019/4878240 · Cited by 52
Arega, B., Mersha, A., Minda, A., Getachew, Y., Sitotaw, A., Gebeyehu, T., & Agunie, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0243945 · Cited by 59
Dahiya, B., Prasad, T., Singh, V., et al. (2020) · Nanomedicine · doi:10.2217/nnm-2020-0258 · Cited by 45
Ullah, I., Javaid, A., Masud, H., Ali, M., Basit, A., Ahmad, W., Younis, F., Yasmin, R., Khan, A., Jabbar, A., et al. (2017) · Journal of Medical Microbiology · doi:10.1099/jmm.0.000449 · Cited by 41
Fantahun, M., Kebede, A., Yenew, B., Gemechu, T., Mamuye, Y., Tadesse, M., Brhane, B., Jibriel, A., Solomon, D., & Yaregal, Z. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222402 · Cited by 38
Self-citationSarfaraz, S., Iftikhar, S., Memon, Y., Zahir, N., Hereker, F. F., & Salahuddin, N. (2018) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2018.08.020 · Cited by 35
Ejeta, E., Beyene, G., Bonsa, Z., et al. (2018) · Journal of Clinical Tuberculosis and Other Mycobacterial Diseases · doi:10.1016/j.jctube.2018.06.002 · Cited by 32
Self-citationFanosie, A., Gelaw, B., Tessema, B., Tesfay, W., Admassu, A., & Yitayew, G. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150646 · Cited by 33
Alemu, A., Tadesse, M., Seid, G., Mollalign, H., Eshetu, K., Sinshaw, W., Abebaw, Y., Amare, M., Dagne, B., Diriba, G., et al. (2020) · BMC Infectious Diseases · doi:10.1186/s12879-020-4817-2 · Cited by 31
Self-citationCombination method for the diagnosis of Tuberculous lymphadenitis in high burden settings
Shetty, D., & Vyas, D. (2022) · Surgical and Experimental Pathology · doi:10.1186/s42047-022-00111-z · Cited by 25
“EPTB is an equally important manifestation of TB which remains undiagnosed due to diagnostic challenges in developing countries.”
BackgroundInfluentialThakkar, K. B., Ghaisas, S. M., & Singh, M. (2016) · Frontiers in Public Health · doi:10.3389/fpubh.2016.00031 · Cited by 41
Li, Z. (2022) · Journal of Analytical Methods in Chemistry · doi:10.1155/2022/2915018 · Cited by 28
Diagnostic Accuracy of Xpert MTB/RIF Assay in Extrapulmonary Tuberculosis
Bankar, S., Set, R., Sharma, D., Shah, D., & Shastri, J. S. (2018) · Indian Journal of Medical Microbiology · doi:10.4103/ijmm.ijmm_18_173 · Cited by 25
Komanapalli, S. K., Prasad, U. S., Atla, B., Nammi, V., & Yendluri, D. (2018) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20184904 · Cited by 25
“Smears for LED fluorescent microscopy were prepared with Auramine O stain which appears bright yellow fluorescent curved bacilli (Figure 2) and reported as negative (zero AFB/1length),“scanty” (1-19), 1+, (20199)2+, (5-50/1 field) 3+ (>50/1 field) acid-fast bacilli (AFB) according to standard IUATLD/WHO scale.”
MethodMukhida, S. S., Vyawahare, C., Mirza, S. B., Gandham, N. R., Khan, S., Kannuri, S., & Bhaumi, S. (2022) · Tzu Chi Medical Journal · doi:10.4103/tcmj.tcmj_86_22 · Cited by 28
“[18], but still lower in comparison to other studies mentioned above [15-17,19,20].”
BackgroundResultGene Xpert MTB/RIF assay for the diagnosis of intra-ocular tuberculosis from vitreous fluid samples
Sharma, K., Gupta, V., Sharma, A., Singh, R., Sharma, M., Aggarwal, K., Bansal, R., Fiorella, P. D., Prakash, S., & Gupta, A. (2016) · Tuberculosis · doi:10.1016/j.tube.2016.11.002 · Cited by 23
Chhajed, P. N., Vaidya, P. J., Mandovra, N. P., Chavhan, V. B., Lele, T. T., Nair, R., Leuppi, J. D., & Saha, A. (2019) · ERJ Open Research · doi:10.1183/23120541.00008-2019 · Cited by 23
Bélard, S., Taccari, F., Kumwenda, T., et al. (2023) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2023.10.021 · Cited by 22
Teste rápido molecular GeneXpert MTB/RIF para diagnóstico da tuberculose
Maschio-Lima, T., Belotti, N. C. U., Nardi, S. M. T., & Pedro, H. D. S. P. (2017) · Revista Pan-Amazônica de Saúde · doi:10.5123/s2176-62232017000200008 · Cited by 46
P.G Resident, D. O. P. M., Singh, D. K. G., Tandon, D. S., Professor and Head, D. O. P. M., Nagdeote, D. S. T., Professor, D. O. P. M., Sharma, D. K., Assistant Professor, D. O. P. M., Kumar, D. A., & P.G Resident, D. O. P. M. (2017) · International Journal of Medical Research and Review · doi:10.17511/ijmrr.2017.i03.05 · Cited by 18
“In a study by Ligthelm et al in 2011 South Africa, CBNAAT was positive in 96% (29 out of 30 patients) of the cases with tubercular peripheral lymphadenopath y in FNA sample [6].”
BackgroundMethodInfluentialAdmassu, W., Ayelign, B., Abebe, G., & Tadesse, M. (2022) · PLoS ONE · doi:10.1371/journal.pone.0262929 · Cited by 17
“Previous studies in our study setting showed high prevalence of smear-negative, pediatric and extrapulmonary TB cases [6, 9, 10].”
ResultSelf-citationDiriba, G., Tola, H. H., Alemu, A., Yenew, B., Gamtesa, D. F., & Kebede, A. (2021) · PLoS ONE · doi:10.1371/journal.pone.0258295 · Cited by 21
Diriba, G., Alemu, A., Eshetu, K., Yenew, B., Gamtesa, D. F., & Tola, H. H. (2022) · PLoS ONE · doi:10.1371/journal.pone.0276701 · Cited by 17
“Type of EPTB Diagnostic Method Risk factors for bacteriologically confirmed TB Tadesse et al [30] 2018 cross- sectional Jimma Facility- based 2015– 2017 572 242 (42.3) Lymph node, CSF, pleural, peritoneal, and pericardial fluids.”
BackgroundMethodInfluentialCartridge based nucleic acid amplification test is superior in diagnosing lymphnode tuberculosis
Chandrappa, N., Rastogi, A., & Bhatnagar, A. K. (2018) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2018.04.001 · Cited by 11
Baikunje, N., Behera, D., Rajwanshi, A., Sharma, M., Sharma, A., & Sharma, K. (2019) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2019.101459 · Cited by 10
Romdhane, E., Arfaoui, A. T., Benabdessalem, C., Ksentini, M., Ferjani, A., Dekhil, N., Lahiani, R., Bchiri, S., Mardassi, H., Barbouche, M., et al. (2020) · Tuberculosis · doi:10.1016/j.tube.2020.102012 · Cited by 10
Siddegowda, M. S., Shivakumar, S., & Mythreyi, M. (2020) · IP Journal of diagnostic pathology and oncology/IP journal of diagnostic pathology and oncology/Journal of diagnostic pathology and oncology · doi:10.18231/j.jdpo.2020.031 · Cited by 8
Che, N., Huang, S.-J., Ma, Y.-L., Han, Y., Liu, Z.-C., Zhang, C., Mu, J., Zhao, D., Qu, Y., Zhang, H., et al. (2017) · Biomedical and environmental sciences : BES · doi:10.3967/bes2017.055 · Cited by 8
Chen, Z.-K., Wu, Z., Ye, T., Lin, C.-Y., & Guo, X. (2025) · PLoS ONE · doi:10.1371/journal.pone.0321507 · Cited by 10
“However, due to the limited number of bacilli in the FNA sample and the possibility to miss out extracting tissue in the lesion site, some samples may not be representative in the case of TB lesion, yielding false negatives on Xpert [16].”
InfluentialAtnafu, A., Desta, K., Girma, S., Hailu, D., Assefa, G., Araya, S., Bekele, D., Wassie, L., & Bobosha, K. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265499 · Cited by 6
“8% which was closer but still lower to what has been shown in this study [22].”
ResultPatil, S., Dhage, S., Umap, P. S., Ghorpade, S. V., & Patharwat, S. (2020) · International Journal of Community Medicine and Public Health · doi:10.18203/2394-6040.ijcmph20201465 · Cited by 12
Role of CBNAAT in the diagnosis of extrapulmonary tuberculosis: a prospective cross-sectional study
Gupta, R., Janmeja, A. K., Kumar, A., Singh, B., & Shridhar, P. K. (2025) · Egyptian Journal of Bronchology · doi:10.1186/s43168-025-00369-3 · Cited by 5
McCullough, A. E., & Leslie, K. O. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-44284-8.00007-7 · Cited by 6
Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
Li, H., He, Z., Liang, J., Li, G., Xie, T., Liu, Y., Li, Z., Feng, X., Xia, Y., & Guo, X. (2020) · BioMed Research International · doi:10.1155/2020/1968487 · Cited by 4
Dai, Y., Wen, Z., Ye, T., Deng, G., Zhang, M., Deng, Q., Yang, Q., Shan, W., Kornfeld, H., Cai, Y., et al. (2018) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2018.06.008 · Cited by 5
Mukherjee, S., Biswas, D., Begum, S., Ghosh, P., Pal, A., & Sarkar, S. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.13618 · Cited by 3
Ocular tuberculosis: Clinicopathologic assortment and diagnostic challenges
Priyatam, K., & Ranju, K. (2019) · Journal of Clinical Research and Ophthalmology · doi:10.17352/2455-1414.000057 · Cited by 5
Purushothaman, G., Sekar, M. G., & Balaraman, S. (2020) · Journal of Evolution of Medical and Dental Sciences · doi:10.14260/jemds/2020/255 · Cited by 4
Arpitha, K., Kumar, M. R., Sirasagi, A. K., & Pattar, P. M. (2021) · National Journal of Laboratory Medicine · doi:10.7860/njlm/2021/47991.2498 · Cited by 3
GeneXpert: a game changer in the detection and diagnosis of childhood tuberculosis
Gandra, N. R., & Gali, J. H. (2017) · International Journal of Contemporary Pediatrics · doi:10.18203/2349-3291.ijcp20175087 · Cited by 3
Diagnosis of lymph node tuberculosis using the GeneXpert MTB/RIF in Bangladesh
Nur, T., Hosna, A., Rayhan, N., & Nazneen, N. (2018) · Mediscope · doi:10.3329/mediscope.v6i1.38939 · Cited by 2
Afellah, M., Zoukal, S., Benmansour, N., Arioua, A., Ouattassi, N., & Alami, M. N. E. A. E. (2024) · Cureus · doi:10.7759/cureus.64979 · Cited by 2
Sayed, M. H., & Sane, K. C. (2024) · Lung India · doi:10.4103/lungindia.lungindia_135_24 · Cited by 3
A., D. K. J., M, D. N., Pandit, G. A., & Londhe, S. S. (2019) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/0501372 · Cited by 2
Cervical tuberculous lymphadenitis: Clinicopathological profile with correlation to ultrasonography
Pradhan, S., Trilochan, B. P., Roy, D., Dhone, P. G., Routray, P. N., & Rai, N. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.8424 · Cited by 4
“Our study showed female predominance which was similar to Patil SB et al[7], Tadesse M et al[8] and Gautam et al[10], but in contrast to Swati Nair et al[9] which reported male to female ratio 1.27:1.”
InfluentialVatsyayan, R., & Sachdeva, K. (2021) · International Journal of Otorhinolaryngology and Head and Neck Surgery · doi:10.18203/issn.2454-5929.ijohns20211577 · Cited by 2
“International Journal of Otorhinolaryngology and Head and Neck Surgery | May 2021 | Vol 7 | Issue 5 Page 830 neck tuberculosis is mainly based upon cytology and conventional smear microscopy in resource-poor settings.(8) However, conventional smear microscopy has low sensitivity due to the paucibacillary nature of les…”
BackgroundYan, Q.-H., Chi, J., Zhang, L., Xue, F., Cui, J., & Kong, H. L. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i28.6698 · Cited by 1
The diagnostic pathway to lymph node excision biopsy in an HIV- and tuberculosis-endemic region
Potelwa, C., Gray, S. C., Malherbe, F., Kloppers, C., Richardson, D., Bailey, J., Brown, K. L., & Verburgh, E. R. (2025) · Southern African Journal of HIV Medicine · doi:10.4102/sajhivmed.v26i1.1752 · Cited by 2
“17,18 The use of Xpert was confined solely to sputum, and was repeated in one third of cases.”
Current Methods and Future of Tuberculosis (TB) Diagnosis
Sood, S., Arya, R. K., Dutta, N., Paul, A., Behera, R. K., Nanda, R. K., & Dutta, G. (2021) · Studies in systems, decision and control · doi:10.1007/978-981-15-9612-4_7 · Cited by 2
Adhikary, M., Das, S., Lath, A., & Phukan, J. P. (2022) · Medical Journal of Babylon · doi:10.4103/mjbl.mjbl_79_22 · Cited by 1
Musculosceletal Tuberculosis with Involvement of Tendon Sheaths and Formation of Synovial Cyst
Zieliński, M., Mazur‐Zielinska, H., & Kozielski, J. (2016) · Advances in respiratory medicine · doi:10.5603/piap.2016.0035 · Cited by 1
Comparison Study of GENEXPERT versus TB MGIT Culture in Extra Pulmonary Tuberculosis
Uppe, A., Sawant, S., Gupta, D., & Nair, G. (2020) · American journal of infectious diseases and microbiology · doi:10.12691/ajidm-8-1-1 · Cited by 1
Junus, H. N., Mertaniasih, N. M., & Soedarsono, S. (2021) · Indonesian Journal of Tropical and Infectious Disease · doi:10.20473/ijtid.v9i1.16043 · Cited by 1
“Microscopic examination with ZiehlNeelsen staining method is first examination to identify acid fast bacilli (AFB) using a binocular microscope but rarely positive results because of paucibacillary nature of MTB bacteria in tissues.(5) Ziehl-Neelsen staining microscopy Sensitivity range 78,3%- 83,33 % 20.”
MethodCorrelation of Cytomorphology Pattern in Tuberculous Lymphadenitis with Microbiological Studies.
Khatib, Y., Sheldon, V. G., Chaudhari, J., Gupte, P., Khare, M., Sable, Y., Patel, R., & Shah, V. (2025) · Journal of The Association of Physicians of India · doi:10.59556/japi.73.0871
Gruźlica narządu ruchu z zajęciem pochewek ścięgnistych i wytworzeniem torbieli galaretowatej
Zieliński, M., Mazur‐Zielinska, H., & Kozielski, J. (2016) · Advances in respiratory medicine · doi:10.5603/arm.46925
“Podobne wyniki (czułość 87,8%, swoistość 91,1%) uzyskano dla systemu GeneXpert MTB/ /RIF, który w 2014 roku został zarekomendowany przez Światową Organizację Zdrowia (WHO, World Health Organization) do analizy materiału z cienkoigłowej biopsji aspiracyjnej przy podejrzeniu gruźlicy pozapłucnej [16].”
BackgroundTuberculous Lymphadenitis: Early Diagnosis by GeneXpert of an Auramine-Negative Case
Munezero, L., Niyikora, N., Mahirane, F., et al. (2020) · Rwanda Journal of Medicine and Health Sciences · doi:10.4314/rjmhs.v3i1.12
“[2] Cervical lymph nodes are the most common sites of involvement and reported in 60-90% of patients with or without involvement of other lymphoid tissue.[3]”
BackgroundChandrakar, J., Sahu, L., & Sahu, S. (2020) · INTERNATIONAL JOURNAL OF SCIENTIFIC RESEARCH · doi:10.36106/ijsr/8434673
Mukherjee, S., Biswas, D., Begum, S., Ghosh, P., Pal, A., & Sarkar, S. (2021) · International Journal of Current Research and Review · doi:10.31782/ijcrr.2021.13805
Ramana, K. V., Premkumar, A., Rao, C. R. N. B., & Kumar, R. S. (2022) · Indian Journal Of Applied Research · doi:10.36106/ijar/9403721
Ahmed, S., Ahmed, S., Tayyaba, U., & Hasan, R. (2022) · International Clinical Pathology Journal · doi:10.15406/icpjl.2022.09.00202
Smith, M. L., Larsen, B. T., & Leslie, K. O. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-79547-0.00016-3
Alharazi, T. H., Al-Zubiery, T., & Alcantara, J. C. (2023) · Research Square · doi:10.21203/rs.3.rs-2937470/v1
Islam, N., Babar, M., Rana, A. H., Aamir, S., Anjum, J., & Khan, M. S. (2023) · Annals of PIMS-Shaheed Zulfiqar Ali Bhutto Medical University · doi:10.48036/apims.v19i3.902
Diagnosis and Treatment of Drug-Resistant Cervical Tuberculous Lymphadenitis
Wang, H., Lu, H., Yi, Y., Luo, Z., & He, Y.-L. (2023) · Springer eBooks · doi:10.1007/978-981-99-8339-1_12 · Cited by 1
Atnafu, A., Wassie, L., Tilahun, M., Girma, S., Alemayehu, M., Dereje, A., Assefa, G., Desta, T., Agize, H., Fisseha, E., et al. (2024) · BMC Infectious Diseases · doi:10.1186/s12879-024-09587-4 · Cited by 2
A case of tuberculous and Listeria-associated lymphadenitis in a migrant from Mexico
Sangiorgi, F., Magrini, E., Leanza, G. M., Catania, F., Carbone, A., Losito, A. R., Maiuro, G., Menchinelli, G., Palucci, I., Graffeo, R., et al. (2024) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2024.116583
Anushree, C., Choudhary, S., Maharana, S. S., Nair, B. S., Krisha, M., & Raju, A. (2024) · Panacea Journal of Medical Sciences · doi:10.18231/j.pjms.2024.133
“This is similar to studies conducted by Mulualem et al, Bryan Rock et al and Adhikary et al 11,12,18 [Table 5].”
Lymph Node Tuberculosis in an Urban Setting in Eastern India during 2016–2024
Kumar, S., Rout, S. S., Mohanty, T., Barik, S. K., & Giri, S. (2025) · Journal of The Academy of Clinical Microbiologists · doi:10.5005/jacm-11020-0019
Gupta, A. K., Yadav, P., Bhattacharya, S., Gautam, A. K., & Kumar, A. (2026) · The Journal of Association of Chest Physicians · doi:10.4103/jacp.jacp_51_25
Preet, K., & Bodh, A. (2026) · Indian Journal of Tuberculosis · doi:10.1016/j.ijtb.2026.07.027
Boudhar, H., Adoum, A., Lahjaouj, M., Loudghiri, M., Bijou, W., Oukessou, Y., Rouadi, S., Abada, R., Roubal, M., & Mahtar, M. (2026) · Global Journal of Medical and Clinical Case Reports · doi:10.17352/gjmccr.000259
Metadata
- Authors
- Tadesse, M., Abebe, G., Abdissa, K., Aragaw, D., Abdella, K., Bekele, A., Bezabih, M., Apers, L., de Jong, B. C., & Rigouts, L.
- Affiliations
- Jimma University (ET)
- Instituut voor Tropische Geneeskunde (BE)
- University of Antwerp (BE)
- Corresponding author
- Abebe, Gemeda
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2015-09-14
- Volume
- 10
- Issue
- 9
- Pages
- e0137471
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC4569183
- OpenAlex
- W2191708934
- Semantic Scholar
- e6b6ebca5ff60c1d002d5d070d66a0ec638fbe68
- Cited by
- 85
- References
- 21
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 10 · 2023: 6 · 2022: 11 · 2021: 8 · 2020: 12 · 2019: 7 · 2018: 10 · 2017: 6 · 2016: 5
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Jimma University
- Vlaamse Interuniversitaire Raad
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Health Sciences › Medicine › Infectious Diseases › Diagnosis and treatment of tuberculosis
- Health Sciences › Medicine › Epidemiology › Mycobacterium research and diagnosis
- Keywords
- tuberculous lymphadenitis, Xpert MTB/RIF, extrapulmonary tuberculosis, Mycobacterium tuberculosis complex, smear microscopy, cytology, sensitivity and specificity, rifampicin resistance, nontuberculous mycobacteria, Ethiopia, molecular tuberculosis diagnosis, N-acetylcysteine
- MeSH terms
- Adolescent, Adult, Bacteriological Techniques, Ethiopia, Female, Humans, Lymph Nodes, Male, Middle Aged, Mycobacterium tuberculosis, Prognosis, Rifampin, Sputum, Tuberculosis, Lymph Node, Biopsy, Fine-Needle, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
